CLCN5 (CLC-5) inhibitors belong to a specialized category of chemical compounds designed to modulate the activity of specific voltage-gated chloride channels. CLCN5 (CLC-5) is a member of the CLC family and are known to facilitate the transport of chloride ions across cell membranes. They are structurally complex, containing both transmembrane and cytoplasmic domains, and they function in various physiological processes such as regulation of cell volume, intracellular pH, and membrane potential. Several types of small molecules can inhibit the activity of these channels, and these inhibitors often share certain chemical features like aromatic rings, sulfonyl groups, or carboxylic acid moieties. These structural elements typically interact with the channel proteins, modulating their ion transport activity.
Experimental agents that inhibit these channels come from a wide range of chemical classes, including but not limited to nonsteroidal anti-inflammatory drugs (NSAIDs), estrogen receptor modulators, and even antipsychotic. The chemical diversity of these inhibitors reflects the complex nature of the channels they target. Certain inhibitors are highly specific, acting solely on CLCN3 or CLC-5, while others may exhibit broader activity, affecting multiple types of chloride channels. Furthermore, these compounds can have different modes of action, such as directly blocking the channel pore or altering the channel's conformation to inhibit ion flow.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
An estrogen receptor modulator that has been reported to inhibit CLCN3. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
An antipsychotic agent in research known to have chloride channel blocking properties. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $31.00 | 3 | |
A nonsteroidal anti-inflammatory drug (NSAID) that has been shown to inhibit chloride channels. | ||||||
CFTR Inhibitor-172 | 307510-92-5 | sc-204680 sc-204680A | 10 mg 50 mg | $165.00 $510.00 | 10 | |
Primarily a CFTR inhibitor, but has some activity against other chloride channels. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $26.00 $77.00 $151.00 $303.00 | 1 | |
An NSAID with chloride channel blocking properties. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker that may have some inhibitory effects on chloride channels. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
An antiparasitic drug that has been reported to inhibit chloride channels, though its specificity for CLCN3 is not clear. | ||||||